New therapeutic options in the medical management of advanced melanoma

Jose Lutzky1

  • 1Melanoma Program, Division of Hematology/Oncology, Mount Sinai Comprehensive Cancer Center, Miami Beach, FL, USA. jlutzky@aptiumoncology.com

Insights

Malignant melanoma incidence is rising, with advanced stages proving difficult to treat. Recent breakthroughs in understanding melanoma's molecular and immunological aspects offer new therapeutic hope.

Area of Science:

  • Oncology
  • Dermatology
  • Immunology

Background:

  • Malignant melanoma incidence, morbidity, and mortality have significantly increased over the last 30 years.
  • Advanced melanoma remains largely incurable, posing a substantial challenge to therapeutic interventions.
  • Limited progress has been made in altering the natural history of advanced melanoma.

Purpose of the Study:

  • To review recent advancements in understanding melanoma.
  • To discuss the impact of new findings on clinical practice.
  • To highlight progress in treating malignant melanoma.

Main Methods:

  • Literature review of recent studies on melanoma.
  • Analysis of molecular alterations in melanoma.
  • Examination of immunologic mechanisms in melanoma.

Main Results:

  • Recent advances in molecular and immunological understanding offer hope for melanoma treatment.
  • Early clinical data suggest significant progress is achievable.
  • New insights are impacting current clinical practices for melanoma management.

Conclusions:

  • Understanding melanoma's molecular and immunological basis is crucial for therapeutic development.
  • Emerging treatments show promise for improving outcomes in advanced melanoma.
  • Continued research is vital to combat the rising burden of malignant melanoma.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...